Experimental Hematology
Volume 38, Issue 1 , Pages 20-26 , January 2010

Constant BCR-ABL transcript level ≥0.1% (IS) in patients with CML responding to imatinib with complete cytogenetic remission may indicate mutation analysis

  • Kateřina Machová Poláková

      Affiliations

    • Institute of Hematology and Blood Transfusion, Department of Molecular Genetics, Prague, Czech Republic
    • Corresponding Author InformationOffprint requests to: Kateřina Machová Poláková, Ph.D., Institute of Hematology and Blood Transfusion, Department of Molecular Genetics, U Nemocnice 1, 128 20 Praha, Czech Republic
    • ,
  • Václava Polívková

      Affiliations

    • Institute of Hematology and Blood Transfusion, Department of Molecular Genetics, Prague, Czech Republic
    • ,
  • Jana Rulcová

      Affiliations

    • Institute of Hematology and Blood Transfusion, Department of Molecular Genetics, Prague, Czech Republic
    • ,
  • Hana Klamová

      Affiliations

    • Institute of Hematology and Blood Transfusion, Clinical Department, Prague, Czech Republic
    • ,
  • Tomáš Jurček

      Affiliations

    • Department of Internal Medicine, Hematology and Oncology, Center of Molecular Biology and Gene Therapy, Faculty Hospital Brno and Masaryk University, Brno, Czech Republic
    • ,
  • Dana Dvořáková

      Affiliations

    • Department of Internal Medicine, Hematology and Oncology, Center of Molecular Biology and Gene Therapy, Faculty Hospital Brno and Masaryk University, Brno, Czech Republic
    • ,
  • Daniela Žáčková

      Affiliations

    • Department of Internal Medicine, Hematology and Oncology, Faculty Hospital Brno and Masaryk University, Brno, Czech Republic
    • ,
  • Zdeněk Pospíšil

      Affiliations

    • Department of Mathematics and Statistics, Faculty of Science, Masaryk University, Brno, Czech Republic
    • ,
  • Jiří Mayer

      Affiliations

    • Department of Internal Medicine, Hematology and Oncology, Faculty Hospital Brno and Masaryk University, Brno, Czech Republic
    • ,
  • Jana Moravcová

      Affiliations

    • Institute of Hematology and Blood Transfusion, Department of Molecular Genetics, Prague, Czech Republic

Received 13 August 2009 ,Revised 8 October 2009 ,Accepted 12 October 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0301-472X(09)00394-4

doi: 10.1016/j.exphem.2009.10.003

Experimental Hematology
Volume 38, Issue 1 , Pages 20-26 , January 2010

Article Tools

* Image Usage & Resolution